Recent share performance and context GSK (LSE:GSK) has recently seen mixed share performance, with a 0.8% decline over the past day and a 3.7% fall over the past week, while remaining positive over ...
Zacks Investment Research on MSN
Here's why GSK (GSK) is a strong value stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
If you are wondering whether GSK is still attractively priced after its recent run, you are not alone and this article is for you. The share price closed at £20.38, with returns of a 7.4% decline over ...
Just over a year ago, the GSK (LSE: GSK) share price was bumping along around a 10-year low. The former FTSE 100 darling had tested investorsâ patience for years, as growth stalled and blockbuster ...
Looking into the current session, GSK Inc. (NYSE:GSK) shares are trading at $47.74, after a 0.99% drop. Over the past month, the stock decreased by 2.26%, but over the past year, it actually increased ...
On 16 March 2026, GSK repurchased 628,000 ordinary shares of 31.25 pence each through BNP Paribas at prices between 2,026p and 2,052p, with a volume-weighted average price of 2,035.82p, as part of its ...
Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. GSK (LSE:GSK) has reached a class action settlement in New York related to advertising ...
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results